The evolving treatment paradigm of chimeric antigen receptor T-cell therapy in lymphoma

Paolo Lopedote, John H. Baird

Open source

DOI: 10.1097/cco.0000000000001169
Published: 2025-07-07
Container: Current Opinion in Oncology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cco.0000000000001169,
  title = {The evolving treatment paradigm of chimeric antigen receptor T-cell therapy in lymphoma},
  author = {Paolo Lopedote and John H. Baird},
  year = {2025},
  journal = {Current Opinion in Oncology},
  doi = {10.1097/cco.0000000000001169},
  url = {https://doi.org/10.1097/cco.0000000000001169}
}

RIS

TY  - JOUR
TI  - The evolving treatment paradigm of chimeric antigen receptor T-cell therapy in lymphoma
AU  - Paolo Lopedote
AU  - John H. Baird
PY  - 2025
JO  - Current Opinion in Oncology
DO  - 10.1097/cco.0000000000001169
UR  - https://doi.org/10.1097/cco.0000000000001169
ER  -

APA

Lopedote, P., & Baird, J. H. (2025). The evolving treatment paradigm of chimeric antigen receptor T-cell therapy in lymphoma. Current Opinion in Oncology. https://doi.org/10.1097/cco.0000000000001169

Source records

crossref · retrieved 2026-09-26T14:20:21.416Z